Background illustration for clinical trials search

Paid Clinical Trials Shreveport

Discover 141 paid clinical trials in Shreveport, Louisiana. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Study of Trastuzumab Deruxtecan Versus Standard of Care Chemotherapy for HER2-Expressing (IHC 3+/2+) Endometrial Cancer

for
Endometrial Cancer
Location: Shreveport LA, San Antonio TX, Cincinnati OH,
Sponsor: Daiichi Sankyo

Sex: Female

Age: 18+

Code: NCT07022483

Phase3, Recruiting

Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer

for
Endometrial Cancer, Recurrent or Progressive Endometrial Cancer
Location: Shreveport LA, Dallas TX, Arlington TX, Bedford TX,
Sponsor: Genmab

Sex: Female

Age: 18+

Code: NCT07166094

Phase3, Recruiting

A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer

for
Ovarian Neoplasms, Fallopian Tube Neoplasms,
Location: Shreveport LA, The Woodlands TX, Webster TX, Austin TX,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT07213804

Phase3, Recruiting

A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)

for
Cervical Cancer
Location: Shreveport LA, Tyler TX, The Woodlands TX,
Sponsor: Merck Sharp & Dohme LLC

Sex: Female

Age: 18+

Code: NCT07216703

Phase3, Recruiting

A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression

for
Ovarian Cancer
Location: Shreveport LA, Tyler TX, Jackson MS, Austin TX,
Sponsor: Incyte Corporation

Sex: Female

Age: 18 - 70+

Code: NCT07023627

Phase2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study of MK-5684 in People With Certain Solid Tumors (MK-5684-015/OMAHA-015)

for
Malignant Neoplasm
Location: Shreveport LA, Houston TX, San Antonio TX, Hastings NE,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06979596

Phase2, Recruiting

A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)

for
Endometrial Cancer
Location: Shreveport LA, Tyler TX, Fort Worth TX, Jackson MS,
Sponsor: Merck Sharp & Dohme LLC

Sex: Female

Age: 18+

Code: NCT06952504

Phase3, Recruiting

WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)

for
Idiopathic Pulmonary Fibrosis
Location: Shreveport LA, Dallas TX, Oklahoma City OK,
Sponsor: Mediar Therapeutics

Sex: All

Age: 40+

Code: NCT06967805

Phase2, Recruiting

A Clinical Study of Raludotatug Deruxtecan in People With Ovarian Cancer (MK-5909-003)

for
Ovarian Cancer Recurrent
Location: Shreveport LA, Fort Worth TX, Oklahoma City OK,
Sponsor: Merck Sharp & Dohme LLC

Sex: Female

Age: 18+

Code: NCT06843447

Phase1, Phase2, Recruiting

Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)

for
Ovarian Cancer
Location: Shreveport LA, Nashville TN, Indianapolis IN,
Sponsor: Daiichi Sankyo

Sex: Female

Age: 18+

Code: NCT06819007

Phase3, Recruiting

Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)

for
Atrial Fibrillation (AF)
Location: Shreveport LA, Tyler TX, West Monroe LA, Greenville TX,
Sponsor: Anthos Therapeutics, Inc.

Sex: All

Age: 65+

Code: NCT05712200

Phase3, Recruiting

A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma

for
Endometrial Adenocarcinoma
Location: Shreveport LA, Little Rock AR, Houston TX,
Sponsor: Acrivon Therapeutics

Sex: Female

Age: 18+

Code: NCT05548296

Phase2, Recruiting

Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer

for
Cervical Cancer
Location: Shreveport LA, Richardson TX, Dallas TX, Arlington TX,
Sponsor: Pfizer

Sex: Female

Age: 18+

Code: NCT06952660

Recruiting

A Study to Learn About the Safety of an Expanded Pneumococcal Vaccine in Healthy Infants

for
Pneumococcal Disease
Location: Shreveport LA, Oklahoma City OK, Union City GA,
Sponsor: Pfizer

Sex: All

Age: 0

Code: NCT07573462

Phase3, Recruiting

Study to Learn About Safety, Tolerability, and Immune Response of a Catch-up Pneumococcal Vaccine in Children and Adolescents

for
Pneumococcal Disease
Location: Shreveport LA, Lafayette LA, Houston TX, League City TX,
Sponsor: Pfizer

Sex: All

Age: 1 - 17

Code: NCT07660198

Phase3, Recruiting

Prospective Case Series Evaluating the Efficacy and Safety of NeoThelium FT for Chronic Pressure Ulcers

for
Pressure Injury
Location: Bossier City LA
Sponsor: NuScience Medical Biologics, LLC

Sex: All

Age: 18+

Code: NCT07158658

Recruiting

A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure

for
Heart Failure
Location: Bossier City LA, Shreveport LA, Longview TX,
Sponsor: Boehringer Ingelheim

Sex: All

Age: 18+

Code: NCT06424288

Phase3, Recruiting

Next Generation Sequencing Versus Traditional Cultures for Clinically Infected Penile Implants: Impact of Culture Identification on Outcomes

for
Penile Implantation, Infections
Location: Bossier City LA, Raleigh NC, Philadelphia PA
Sponsor: MicroGenDX

Sex: Male

Age: 18 - 70+

Code: NCT05287438

Recruiting

Water Vapor Ablation for Prostate Cancer: Long-Term Registry

for
Prostate Cancer
Location: Bossier City LA, San Antonio TX, Woodbury MN,
Sponsor: Francis Medical Inc.

Sex: Male

Age: 0+

Code: NCT07455058

Recruiting

A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma

for
Multiple Myeloma
Location: Shreveport LA, Dallas TX, Houston TX, Kansas City MO,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT05552222

Phase3, Recruiting